id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2016-0028-0002,APHIS,APHIS-2016-0028,"Risk Analysis:  Infectious Laryngotracheitis-Marek's Disease-Newcastle Disease Vaccine, Serotype 3, Live Marek's Disease Vector",Supporting & Related Material,Risk Assessment,2016-05-19T04:00:00Z,2016,5,,,2016-05-19T13:48:48Z,,0,0,0900006481fdd7ba
APHIS-2016-0028-0003,APHIS,APHIS-2016-0028,"Environmental Assessment For Field Testing of an Infectious Laryngotracheitis - Marek’s Disease - Newcastle Disease Vaccine, Serotype 3, Live Marek’s Disease Vector",Supporting & Related Material,Environmental Assessment,2016-05-19T04:00:00Z,2016,5,,,2016-05-20T12:23:27Z,,0,0,0900006481fde12a
APHIS-2016-0028-0001,APHIS,APHIS-2016-0028,"Environmental Assessments; Availability, etc.: Field Testing of a Vaccine for use Against Infectious Laryngotracheitis, Marek's Disease, and Newcastle Disease",Notice,Availability of Environmental Assessment,2016-05-12T04:00:00Z,2016,5,2016-05-12T04:00:00Z,2016-06-14T03:59:59Z,2016-05-19T13:45:23Z,2016-11148,0,0,0900006481fc74e0